Mura M - Search Results

1

Recombinant measles vaccine expressing malaria antigens induces long-term memory and protection in mice.

Mura M, Ruffié C, Combredet C, Aliprandini E, Formaglio P, Chitnis CE, Amino R, Tangy F. Mura M, et al. NPJ Vaccines. 2019 Feb 27;4:12. doi: 10.1038/s41541-019-0106-8. eCollection 2019. NPJ Vaccines. 2019. PMID: 30820355 Free PMC article.

2

Comparative analysis of viral RNA signatures on different RIG-I-like receptors.

Sanchez David RY, Combredet C, Sismeiro O, Dillies MA, Jagla B, Coppée JY, Mura M, Guerbois Galla M, Despres P, Tangy F, Komarova AV. Sanchez David RY, et al. Among authors: mura m. Elife. 2016 Mar 24;5:e11275. doi: 10.7554/eLife.11275. Elife. 2016. PMID: 27011352 Free PMC article.

3

Nonencapsidated 5' Copy-Back Defective Interfering Genomes Produced by Recombinant Measles Viruses Are Recognized by RIG-I and LGP2 but Not MDA5.

Mura M, Combredet C, Najburg V, Sanchez David RY, Tangy F, Komarova AV. Mura M, et al. J Virol. 2017 Sep 27;91(20):e00643-17. doi: 10.1128/JVI.00643-17. Print 2017 Oct 15. J Virol. 2017. PMID: 28768856 Free PMC article.

4

DI-tector: defective interfering viral genomes' detector for next-generation sequencing data.

Beauclair G, Mura M, Combredet C, Tangy F, Jouvenet N, Komarova AV. Beauclair G, et al. Among authors: mura m. RNA. 2018 Oct;24(10):1285-1296. doi: 10.1261/rna.066910.118. Epub 2018 Jul 16. RNA. 2018. PMID: 30012569 Free PMC article.

5

hCD46 receptor is not required for measles vaccine Schwarz strain replication in vivo: Type-I IFN is the species barrier in mice.

Mura M, Ruffié C, Billon-Denis E, Combredet C, Tournier JN, Tangy F. Mura M, et al. Virology. 2018 Nov;524:151-159. doi: 10.1016/j.virol.2018.08.014. Epub 2018 Sep 7. Virology. 2018. PMID: 30199752 Free article.

6

Immunoprofiling Identifies Functional B and T Cell Subsets Induced by an Attenuated Whole Parasite Malaria Vaccine as Correlates of Sterile Immunity.

Mura M, Lu P, Atre T, Bolton JS, Duncan EH, Chaudhury S, Bergmann-Leitner ES. Mura M, et al. Vaccines (Basel). 2022 Jan 14;10(1):124. doi: 10.3390/vaccines10010124. Vaccines (Basel). 2022. PMID: 35062785 Free PMC article.

7

Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control.

Mura M, Simon F, Pommier de Santi V, Tangy F, Tournier JN. Mura M, et al. Vaccines (Basel). 2022 Sep 18;10(9):1555. doi: 10.3390/vaccines10091555. Vaccines (Basel). 2022. PMID: 36146633 Free PMC article. Review.

8

[Exploration of vaccine immunogenicity].

Denis J, Mura M, Trignol A, Tournier JN. Denis J, et al. Among authors: mura m. Rev Francoph Lab. 2022 Mar;2022(540):40-52. doi: 10.1016/S1773-035X(22)00098-3. Epub 2022 Mar 4. Rev Francoph Lab. 2022. PMID: 35284007 Free PMC article. French.

9

Differential Homing Receptor Profiles of Lymphocytes Induced by Attenuated versus Live Plasmodium falciparum Sporozoites.

Mura M, Atre T, Savransky T, Bergmann-Leitner ES. Mura M, et al. Vaccines (Basel). 2022 Oct 21;10(10):1768. doi: 10.3390/vaccines10101768. Vaccines (Basel). 2022. PMID: 36298634 Free PMC article.

10

[Vaccination against malaria].

Mura M. Mura M. Med Trop Sante Int. 2023 May 3;3(2):mtsi.v3i2.2023.325. doi: 10.48327/mtsi.v3i2.2023.325. eCollection 2023 Jun 30. Med Trop Sante Int. 2023. PMID: 37525687 Free PMC article. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

611 results

Search Page